For reprint rights or to purchase a copy of your Daily Journal photo, email Jeremy_Ellis@dailyjournal.com for prices or call 213-229-5424.

To buy more copies, call 866-531-1492 or email subscribe@dailyjournal.com
This is the property of the Daily Journal Corporation and fully protected by copyright. It is made available only to Daily Journal subscribers for personal or collaborative purposes and may not be distributed, reproduced, modified, stored or transferred without written permission. Please click "Reprint" to order presentation-ready copies to distribute to clients or use in commercial marketing materials or for permission to post on a website. and copyright (showing year of publication) at the bottom.
Subscribe to the Daily Journal for access to Daily Appellate Reports, Verdicts, Judicial Profiles and more...

Civil Litigation

Jul. 24, 2025

Investors: Law firms helped suppress valuation in acquisition scheme

Investors accuse Sofie Biosciences, two law firms, and Kroll of conspiring to undervalue a nuclear medicine asset, defrauding stakeholders--including Toy Story writer Joel Cohen--before a $500 million acquisition.

Investors: Law firms helped suppress valuation in acquisition scheme
Shawn Shaffie, of Parker Shaffie LLP, representing the plaintiffs.

A sweeping investor fraud lawsuit accuses the top brass of a Southern California bioscience firm--along with two major law firms and a national valuation company--of orchestrating a multimillion-dollar scheme to cheat investors.

The complaint filed in Los Angeles County Superior Court this week claims that Sofie Biosciences Inc. and its advisers engineered a deliberately suppressed valuation of a lucrative nuclear medicine asset to protect insider profits ahead of a $500 million ...

To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!

Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)

Already a subscriber?

Enewsletter Sign-up



By using our website, you agree to our use of cookies in accordance with our cookie policy. You can learn more about how we use cookies by reviewing our Privacy Policy here.